Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial - Concepedia

Concepedia

Publication | Closed Access

Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

208

Citations

24

References

2023

Year

Brian G. Feagan, Bruce E. Sands, William J. Sandborn, Matthew Germinaro, Marion Vetter, Jie Shao, Shihong Sheng, Jewel Johanns, Julián Panés, Dilara Kalimullina,

The Lancet. Gastroenterology & hepatology

Systemic TreatmentGolimumab MonotherapyGastroenterologyPathologyUlcerative ColitisPhase 2Medicine

References

	Year	Citations

Page 1